| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.09B | -36.2% |
| Gross profit | ¥0.02B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | -132.1% |
| Gross margin | 18.1% | Net margin -6.0% |
| Revenue Q/Q | -50.2% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.07B | 81.9% |
| R&D | ¥0.00B | 5.3% |
| SG&A | ¥0.02B | 20.1% |
| Tax & other | ¥0.00B | 0.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
探路者 ・ 莱美药业 ・ 汉威科技 ・ 天海防务 ・ 安科生物 ・ ST豆神 ・ 鼎汉技术 ・ 华测检测 ・ 新宁物流 ・ 北陆药业 ・ 网宿科技 ・ 中元股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies